JP2022511568A5 - - Google Patents
Info
- Publication number
- JP2022511568A5 JP2022511568A5 JP2021533154A JP2021533154A JP2022511568A5 JP 2022511568 A5 JP2022511568 A5 JP 2022511568A5 JP 2021533154 A JP2021533154 A JP 2021533154A JP 2021533154 A JP2021533154 A JP 2021533154A JP 2022511568 A5 JP2022511568 A5 JP 2022511568A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- smad4
- subject
- glial
- under conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024104638A JP2024129091A (ja) | 2018-12-11 | 2024-06-28 | 統合失調症及び他の神経精神障害の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862778145P | 2018-12-11 | 2018-12-11 | |
| US62/778,145 | 2018-12-11 | ||
| PCT/US2019/065742 WO2020123663A1 (en) | 2018-12-11 | 2019-12-11 | Methods of treating schizophrenia and other neuropsychiatric disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024104638A Division JP2024129091A (ja) | 2018-12-11 | 2024-06-28 | 統合失調症及び他の神経精神障害の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022511568A JP2022511568A (ja) | 2022-01-31 |
| JP2022511568A5 true JP2022511568A5 (cg-RX-API-DMAC7.html) | 2022-12-15 |
| JP7518547B2 JP7518547B2 (ja) | 2024-07-18 |
Family
ID=69160318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533154A Active JP7518547B2 (ja) | 2018-12-11 | 2019-12-11 | 統合失調症及び他の神経精神障害の治療方法 |
| JP2024104638A Pending JP2024129091A (ja) | 2018-12-11 | 2024-06-28 | 統合失調症及び他の神経精神障害の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024104638A Pending JP2024129091A (ja) | 2018-12-11 | 2024-06-28 | 統合失調症及び他の神経精神障害の治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220025379A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3894556A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7518547B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN113728103B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019396450B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3122289A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020123663A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9709553B2 (en) | 2008-05-08 | 2017-07-18 | University Of Rochester | Treating myelin diseases with optimized cell preparations |
| EP3766962B1 (en) | 2013-02-06 | 2025-10-22 | University of Rochester | Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders |
| US9724432B2 (en) | 2015-04-30 | 2017-08-08 | University Of Rochester | Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder |
| EP3621434B1 (en) | 2017-05-10 | 2026-07-15 | University of Rochester | Glial progenitor cells for use in treating schizophrenia |
| US12303549B2 (en) | 2018-06-21 | 2025-05-20 | University Of Rochester | Methods of treating or inhibiting onset of Huntington's disease |
| CN118924886A (zh) * | 2023-03-16 | 2024-11-12 | 郑州大学 | 肿瘤共享新抗原表位肽或其编码核酸的新用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080119427A1 (en) | 1996-06-06 | 2008-05-22 | Isis Pharmaceuticals, Inc. | Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation |
| JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
| US6794499B2 (en) | 1997-09-12 | 2004-09-21 | Exiqon A/S | Oligonucleotide analogues |
| US6838283B2 (en) | 1998-09-29 | 2005-01-04 | Isis Pharmaceuticals Inc. | Antisense modulation of survivin expression |
| BRPI0008131B8 (pt) | 1999-02-12 | 2021-05-25 | Daiichi Sankyo Co Ltd | composto ou um sal deste, análogo de oligonucleotídeo, composição farmacêutica, sonda para um gene,iniciador para começar a amplificação, uso de um análogo de oligonucleotídeo ou de um sal deste farmacologicamente aceitável, agente antisentido, e, agente antígeno |
| US6013787A (en) | 1999-02-23 | 2000-01-11 | Isis Pharmaceuticals Inc. | Antisense modulation of Smad4 expression |
| US7098192B2 (en) | 1999-04-08 | 2006-08-29 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of STAT3 expression |
| US7179796B2 (en) | 2000-01-18 | 2007-02-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of PTP1B expression |
| WO2003070918A2 (en) | 2002-02-20 | 2003-08-28 | Ribozyme Pharmaceuticals, Incorporated | Rna interference by modified short interfering nucleic acid |
| JP2005504020A (ja) | 2001-07-03 | 2005-02-10 | アイシス・ファーマシューティカルス・インコーポレーテッド | ヌクレアーゼ耐性キメラオリゴヌクレオチド |
| EP1857547B2 (en) | 2002-08-05 | 2020-12-02 | Silence Therapeutics GmbH | Further novel forms of interfering RNA molecules |
| EP2182063A3 (en) | 2003-09-18 | 2012-07-18 | Isis Pharmaceuticals, Inc. | Modulation of EIF4E expression |
| US7128264B2 (en) | 2004-07-23 | 2006-10-31 | Symbol Technologies, Inc: | Electro-optical reader with improved performance in high intensity ambient light |
| JP4428296B2 (ja) | 2005-06-10 | 2010-03-10 | セイコーエプソン株式会社 | 表示パネルモジュールおよび表示装置 |
| US9962558B2 (en) * | 2005-08-05 | 2018-05-08 | Gholam A. Peyman | Methods to regulate polarization and enhance function of cells |
| EP2206724A1 (en) | 2005-12-13 | 2010-07-14 | Kyoto University | Nuclear reprogramming factor |
| DK3399025T3 (da) | 2007-03-23 | 2025-06-16 | Wisconsin Alumni Res Found | Omprogrammering af somatiske celler |
| JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| EP2315829B1 (en) | 2008-08-08 | 2015-02-11 | Mayo Foundation For Medical Education And Research | Induced pluripotent stem cells |
| WO2011062963A2 (en) | 2009-11-17 | 2011-05-26 | Vitro Diagnositics, Inc. | Induced puripotent stem cells and related methods |
| US9005967B2 (en) | 2010-01-22 | 2015-04-14 | Kyoto University | Myc variants improve induced pluripotent stem cell generation efficiency |
| EP2723861A4 (en) * | 2011-06-21 | 2014-12-10 | Alnylam Pharmaceuticals Inc | COMPOSITIONS AND METHODS FOR INHIBITING HEPCIDINE ANTIMICROBIAL PEPTIDE (HAMP) OR THE ASSOCIATED GENE EXPRESSION |
| AU2012332269B2 (en) * | 2011-11-04 | 2018-05-31 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (DA) neurons for engraftment |
| US9035039B2 (en) | 2011-12-22 | 2015-05-19 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing SMAD4 |
| US20180263226A1 (en) | 2015-01-16 | 2018-09-20 | The Board Of Regents Of The University Of Texas System | Compositions and methods for creating pancreatic cancer animal model |
-
2019
- 2019-12-11 AU AU2019396450A patent/AU2019396450B2/en active Active
- 2019-12-11 CN CN201980091600.4A patent/CN113728103B/zh active Active
- 2019-12-11 CA CA3122289A patent/CA3122289A1/en active Pending
- 2019-12-11 EP EP19836294.9A patent/EP3894556A1/en active Pending
- 2019-12-11 WO PCT/US2019/065742 patent/WO2020123663A1/en not_active Ceased
- 2019-12-11 US US17/413,384 patent/US20220025379A1/en active Pending
- 2019-12-11 JP JP2021533154A patent/JP7518547B2/ja active Active
- 2019-12-11 CN CN202510144182.8A patent/CN119925614A/zh active Pending
-
2024
- 2024-06-28 JP JP2024104638A patent/JP2024129091A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xu et al. | Current knowledge of microglia in traumatic spinal cord injury | |
| JP7406793B2 (ja) | 2テイル自己デリバリー型siRNAおよび関連方法 | |
| EP3394259B1 (en) | Compositions and methods for decreasing tau expression | |
| CN111433361B (zh) | 天使综合征反义治疗 | |
| PE20211749A1 (es) | Oligonucleotidos antisentido que actuan sobre alfa-sinucleina, y usos de estos | |
| TWI462741B (zh) | 使用微rna 195提供神經保護作用的方法 | |
| JP2011515357A5 (cg-RX-API-DMAC7.html) | ||
| JP2022511568A (ja) | 統合失調症及び他の神経精神障害の治療方法 | |
| JP2009533475A5 (cg-RX-API-DMAC7.html) | ||
| WO2024238828A3 (en) | Gene editing systems and compositions for treatment of hemoglobinopathies and methods of using the same | |
| JP2021529169A5 (cg-RX-API-DMAC7.html) | ||
| US10947538B2 (en) | Allele-specific gene suppression | |
| JP2023506842A5 (cg-RX-API-DMAC7.html) | ||
| KR20240099216A (ko) | 슈반 세포로의 표적화 전달을 위한 설계자 세포외 소낭 | |
| CN116376910B (zh) | 一种三叉神经痛的标志物及治疗三叉神经的药物 | |
| JP2021527649A5 (cg-RX-API-DMAC7.html) | ||
| CN103656685B (zh) | microRNA-219在制备抗癫痫药物中的应用 | |
| MX2022007193A (es) | Métodos para tratar la enfermedad de parkinson. | |
| JP2024515289A5 (cg-RX-API-DMAC7.html) | ||
| MX2022003108A (es) | Composicion y metodo para inhibir la acumulacion, agregacion y formacion de ovillos de proteina tau. | |
| RU2839721C2 (ru) | Антисмысловые олигонуклеотиды, нацеленные на ген cav3.1, и их применения | |
| US12589133B2 (en) | Methods of downregulating CCL20 genes for treatment of traumatic brain injuries | |
| WO2019186559A1 (en) | Microglia modulators for use in treatment of depression | |
| CN106075392B (zh) | 促红细胞生成素衍生物在听力保护上的应用 | |
| WO2024259063A2 (en) | Antisense oligonucleotides as fragile x syndrome therapeutics |